2014
DOI: 10.7314/apjcp.2014.15.18.7831
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Autologous and Homologous Blood Transfusion on Interleukins and Tumor Necrosis Factor-α in Peri-operative Patients with Esophageal Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 15 publications
1
8
0
Order By: Relevance
“…It is known that allogeneic transfusion can aggravate perioperative immunosuppression in cancer patients, and autogenous transfusion seems to be superior to allogeneic transfusion [51, 52], but Harlaar et al did not find any benefit from autologous transfusion compared with allogeneic transfusion after long-term follow-up in colorectal cancer patients [53]. The clinical data for autogenous transfusion in cancer patients are sparse, and the safety of autogenous transfusion is still a big concern in the clinic, as autogenous transfusion has the potential risk to induce iatrogenic metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…It is known that allogeneic transfusion can aggravate perioperative immunosuppression in cancer patients, and autogenous transfusion seems to be superior to allogeneic transfusion [51, 52], but Harlaar et al did not find any benefit from autologous transfusion compared with allogeneic transfusion after long-term follow-up in colorectal cancer patients [53]. The clinical data for autogenous transfusion in cancer patients are sparse, and the safety of autogenous transfusion is still a big concern in the clinic, as autogenous transfusion has the potential risk to induce iatrogenic metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous hypotheses had been postulated and the most possible explanation for this phenomenon was blood transfusion-induced immunomodulation. It had been illustrated that perioperative blood transfusion markedly diminished the number of T cell subgroups, nature killer cells and immunoglobins as well as altered cytokine secretions in patients who underwent oncologic surgeries (Guo et al, 2014;Xing et al, 2014). Reasonably, worse outcome could be predicted for blood transfusion during the peri-operative period in either cancer groups or posttransplantation groups according to their pre-existed immunosusceptibility and medication-associated immunosuppression status.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, the examination of potential transfusion side effects and events should be the same or similar for autologous and allogeneic transfusions [5][6][7][22][23][24] . Namely, autologous transfusions have no risk of infectious (virus) and immunemediated complications (reduced "biohazard"), but carry a similar risk of bacterial contamination following storage (PAD), circulation volume overload, and misadministration compared with normal allogeneic units.…”
Section: Regardless Of the Implementation Of Different Effective Prevmentioning
confidence: 99%
“…Seldom, due to platelet and WBC activation (in the course blood processing), transfusionrelated acute lung injury (TRALI) can occur -termed also as the "syndrome of salvaged blood". Finally, infection and malignancy in the surgical field are contraindications for performing of the PBR manner 1,[3][4][5][6][22][23][24] .…”
Section: Perioperative Blood Recovery/salvagementioning
confidence: 99%